FORMULATION AND EVALUATION OF BILAYER TABLET CONTAINING DICLOFENAC SODIUM AS SUSTAINED RELEASE AND ALOE VERA GEL POWDER AS IMMEDIATE RELEASE

  • HARSHAD PADEKAR VJSM’s Vishal Institute of Pharmaceutical Education and Research Ale, Tal–Junnar Dist-Pune (412411)
  • OMKAR LOHOTE VJSM’s Vishal Institute of Pharmaceutical Education and Research Ale, Tal–Junnar Dist-Pune (412411)

Abstract

Objective: The objective of the present investigation is to design formulate and characterized the bilayer tablet containing Diclofenac sodium and Aloe Vera gel powder. In which diclofenac sodium is sustained release and Aloe Vera gel powder is immediate release. In order to produce a single dosage form containing two different classes, drug are widely prescribed by the physician to have better patient compliance.


Methods: Bilayer tablet was prepared by direct compression, The immediate release layer of Aloe Vera gel powder was prepared by using different excipients such as starch, sodium starch glycolate, lactose, talc etc. sustained release layer of diclofenac sodium was prepared by using HPMC K4M, lactose, Talc Magnesium stearate, talc etc. for preparation of bilayer tablet sodium starch glycolate are use as super disintegrants in immediate release tablet and HPMC K4M are use as controlled release polymer. Various Preformulation parameter i.e. Identification, melting point, compatibility study, solubility are checked. Micromeritics properties of powder blend such as bulk density, tapped density, hausner’s ratio, Carr’s index, angle of repose are performed. Post-compression parameter was done such as hardness, friability, weight variation, drug content uniformity, thickness, in vitro drug release.


Results: Result was found within the limit of the standard of optimized formulation. The drug release of the tablet was in the range of 82 to 92%in 8 h.


Conclusion: Bilayer tablet was prepared by optimized batches of both layers. The prepared tablets showed satisfactory results for various evaluation parameters. The optimized formulation based on all the parameter A1 (Sodium starch glycolate) is selected for the immediate release layer and D3 (HPMC K4M) was selected for the controlled release layer. The drug release mechanism was found to be zero order release depends upon diffusion.

Keywords: Bilayer tablet, Diclofenac sodium, Aloe Vera gel powder, HPMC K4M, Immediate release, Sustained release, Direct compression

References

1. B Prabakaran, K Elango, K Ramesh Kumar, D Jaison. Formulation development and evaluation of gastroretentive bilayer floating tablets of simvastatin and telmisartan. Int J Pharma Res Rev 2016;5:9-18.
2. Prabhakar Shirse. Formulation and evaluation of bilayer tablets of diclofenac sodium with ranitidine HCL for sustained and immediate release. J Appl Pharm Sci 2012;2:136-41.
3. https://en.wikipedia.org/wiki/Diclofenac. [Last accessed in 10 Mar 2019]
4. Bharath Kumar N, S Bharath, R Deveswaran, BV Basavaraj, V Madhavan, Extended drug release retarding effect of aloe vera gel in the design of tablet dosage form. IJPBS 2012;2:54-9.
5. Karthik Varma V. Excipients used in the formulation of the tablet. Res Rev J Chem 2016;5:143-5.
6. Lachman L, Lieberman HA, Kanig JL. The theory and practice of Industrial pharmacy, Varghese Publishing House Bombay; special Indian edition; 2009.
7. Gurdeep R Chatwal, Sham K Anand. Instrumental methods of chemical analysis. 3rd ed Himalaya Publishing House, Mumbai; 2011. p. 244.
8. Shivani Kala, Divya Juyal. Preformulation and characterization studies of aceclofenac active ingredient. Pharma Innovation J 2016;5:110-9.
9. Indian Pharmacopoeia. Ministry of Health and Family Welfare. Ghaziabad, India: The Indian Pharmacopoeia commission; 2010. p. 3.
10. United States Pharmacopoeia. 30th edition NF 25-2007, The Official Compendia of Standards. 643, Pharmacopoeial forum; 2007. p. 28.
Statistics
151 Views | 92 Downloads
Citatons
How to Cite
PADEKAR, H., and O. LOHOTE. “FORMULATION AND EVALUATION OF BILAYER TABLET CONTAINING DICLOFENAC SODIUM AS SUSTAINED RELEASE AND ALOE VERA GEL POWDER AS IMMEDIATE RELEASE”. International Journal of Current Pharmaceutical Research, Vol. 11, no. 4, July 2019, pp. 70-78, doi:10.22159/ijcpr.2019v11i4.34923.
Section
Original Article(s)